CPHI vs DVA · rev $4.5M vs P/E 14, rev $12.82B
China Pharma Holdings Inc (CPHI) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CPHI currently screens at market cap $29.0M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CPHI and DVA stock pages for the full models.
Not investment advice.